The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rasagiline Krka 1 mg tablets

1 milligram(s) Tablet

Krka d.d., Novo mestoPA1347/088/001

Main Information

Trade NameRasagiline Krka 1 mg tablets
Active SubstancesRasagiline
Strength1 milligram(s)
Dosage FormTablet
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/088/001

Group Information

ATC CodeN04BD Monoamine oxidase B inhibitors
N04BD02 rasagiline


Licence Issued30/10/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListRasagiline 1mg Tablets
Interchangeable List CodeIC0112-039-002
Interchangeable List DocumentPDF of Interchangeable List
« Back